Risk factors and renal outcomes of AKI in children with secondary steroid-resistant nephrotic syndrome

被引:2
作者
Yu, Nannan [1 ]
Ouyang, Xiaojun [1 ]
Li, Jie [1 ]
Gao, Jie [1 ]
Zeng, Shuhan [1 ]
Zhuang, Hongjie [1 ]
Jiang, Mengjie [1 ]
Pei, Yuxin [1 ]
Jiang, Xiaoyun [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat Nephrol & Rheumatol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Secondary steroid-resistant nephrotic syndrome; acute kidney injury; children; risk factors; outcome; ACUTE KIDNEY INJURY; CHILDHOOD; RECOVERY;
D O I
10.1080/0886022X.2024.2314637
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute kidney injury (AKI) is increasingly prevalent in children with nephrotic syndrome (NS). It is associated with adverse outcomes in NS, especially steroid-resistant nephrotic syndrome (SRNS). The incidence, risk factors and outcomes of AKI in secondary SRNS remain undefined. The main objectives of this study were to determine the risk factors and prognosis of AKI in hospitalized children with secondary SRNS. Material and methods: This retrospective study was conducted from January 2014 to December 2019, involving 172 hospitalizations with secondary SRNS admitted to the First Affiliated Hospital of Sun Yat-sen University. AKI was defined and classified in accordance with the 2012 Kidney Disease Improving Global Outcomes (KDIGO) guidelines. Results: AKI was found in 67 (39.0%) of 172 hospitalizations with secondary SRNS. Average age of onset in our group is 4.4 (3.1, 6.7) years with AKI and 3.7 (1.8, 5.6) years without AKI. Urea nitrogen level is 5.9 (4.1, 10.0) mmol/L with AKI and 5.1 (3.7, 7.0) mmol/L. Uric acid level is 446.0 (340.0, 567.0) umol/L with AKI and 401.0 (303.0, 496.0) umol/L. 24-h urinary protein level is 4.14 (2.9, 6.5) g with AKI and 2.5 (1.3, 5.3) without AKI. Multivariate logistic regression revealed that infection (OR = 5.287; 95% confidence interval, 2.349 to 11.899; p < 0.001), age at onset (OR = 1.180; 95% confidence interval, 1.032 to 1.349; p = 0.015) and uric acid level (OR = 1.003; 95% confidence interval, 1.000 to 1.006; p = 0.031) were significantly associated with the development of AKI in children with secondary SRNS. Among 72 children with secondary SRNS, six went to end-stage kidney disease (ESKD). Children in the AKI group were more likely to progress to ESKD compared with children in the non-AKI group (p = 0.017) with a median follow-up of 48.5months. Conclusion: AKI occurred in 39.0% of total hospitalizations associated with secondary SRNS. Risk factors including infection, age of onset, and uric acid level are associated with AKI in children with secondary SRNS. Furthermore, AKI was identified as a risk factor for the progression of secondary SRNS to ESKD.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome
    Hamasaki, Yuko
    Yoshikawa, Norishige
    Hattori, Shinzaburo
    Sasaki, Satoshi
    Iijima, Kazumoto
    Nakanishi, Koichi
    Matsuyama, Takeshi
    Ishikura, Kenji
    Yata, Nahoko
    Kaneko, Tetsuji
    Honda, Masataka
    PEDIATRIC NEPHROLOGY, 2009, 24 (11) : 2177 - 2185
  • [2] Risks and renal outcomes of severe acute kidney injury in children with steroid-resistant nephrotic syndrome
    Ishiwa, Sho
    Sato, Mai
    Kamei, Koichi
    Nishi, Kentaro
    Kanamori, Toru
    Okutsu, Mika
    Ogura, Masao
    Sako, Mayumi
    Ito, Shuichi
    Orihashi, Yasushi
    Ishikura, Kenji
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (07) : 700 - 708
  • [3] Long-Term Outcome of Secondary Steroid-Resistant Nephrotic Syndrome in Chinese Children
    Ying, Daojing
    Liu, Wangkai
    Chen, Lizhi
    Rong, Liping
    Lin, Zhilang
    Wen, Sijia
    Zhuang, Hongjie
    Li, Jinhua
    Jiang, Xiaoyun
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (08): : 2144 - 2150
  • [4] Endothelial Dysfunction in Children with Steroid-Resistant Nephrotic Syndrome
    Kari, Jameela Abdulaziz
    Quinlan, Catherine
    Deanfield, John
    Shroff, Rukshana
    Tullus, Kjell
    IRANIAN JOURNAL OF PEDIATRICS, 2017, 27 (04)
  • [5] Immunosuppressive Therapy in Children With Steroid-Resistant Nephrotic Syndrome
    Li, Jing
    Li, Qin
    Lu, Jinmiao
    Li, Zhiping
    IRANIAN JOURNAL OF PEDIATRICS, 2018, 28 (01)
  • [6] Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
    Trautmann, Agnes
    Seide, Svenja
    Lipska-Zietkiewicz, Beata S.
    Ozaltin, Fatih
    Szczepanska, Maria
    Azocar, Marta
    Jankauskiene, Augustina
    Zurowska, Alexandra
    Caliskan, Salim
    Saeed, Bassam
    Morello, William
    Emma, Francesco
    Litwin, Mieczyslaw
    Tsygin, Alexey
    Fomina, Svitlana
    Wasilewska, Anna
    Melk, Anette
    Benetti, Elisa
    Gellermann, Jutta
    Stajic, Natasa
    Tkaczyk, Marcin
    Baiko, Sergey
    Prikhodina, Larisa
    Csaicsich, Dagmar
    Medynska, Anna
    Krisam, Regina
    Breitschwerdt, Heike
    Schaefer, Franz
    PEDIATRIC NEPHROLOGY, 2023, 38 (05) : 1499 - 1511
  • [7] Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
    Agnes Trautmann
    Svenja Seide
    Beata S. Lipska-Ziętkiewicz
    Fatih Ozaltin
    Maria Szczepanska
    Marta Azocar
    Augustina Jankauskiene
    Alexandra Zurowska
    Salim Caliskan
    Bassam Saeed
    William Morello
    Francesco Emma
    Mieczyslaw Litwin
    Alexey Tsygin
    Svitlana Fomina
    Anna Wasilewska
    Anette Melk
    Elisa Benetti
    Jutta Gellermann
    Natasa Stajic
    Marcin Tkaczyk
    Sergey Baiko
    Larisa Prikhodina
    Dagmar Csaicsich
    Anna Medynska
    Regina Krisam
    Heike Breitschwerdt
    Franz Schaefer
    Pediatric Nephrology, 2023, 38 : 1499 - 1511
  • [8] Risks and renal outcomes of severe acute kidney injury in children with steroid-resistant nephrotic syndrome
    Sho Ishiwa
    Mai Sato
    Koichi Kamei
    Kentaro Nishi
    Toru Kanamori
    Mika Okutsu
    Masao Ogura
    Mayumi Sako
    Shuichi Ito
    Yasushi Orihashi
    Kenji Ishikura
    Clinical and Experimental Nephrology, 2022, 26 : 700 - 708
  • [9] Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome
    Li, Zhihui
    Duan, Cuirong
    He, Jinhua
    Wu, Tianhui
    Xun, Mai
    Zhang, Yi
    Yin, Yan
    PEDIATRIC NEPHROLOGY, 2010, 25 (05) : 883 - 888
  • [10] Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome
    Yuko Hamasaki
    Norishige Yoshikawa
    Shinzaburo Hattori
    Satoshi Sasaki
    Kazumoto Iijima
    Koichi Nakanishi
    Takeshi Matsuyama
    Kenji Ishikura
    Nahoko Yata
    Tetsuji Kaneko
    Masataka Honda
    Pediatric Nephrology, 2009, 24 : 2177 - 2185